Join us on an amazing journey towards next-generation treatments for CNS disorders:Launch of Neuroprotection,a new high-quality journal in translational neuroscience  

作　　者：Xunming Ji Piotr Walczak Heleen M.M.van Beusekom Ana I.Casas Andrew Clarkson Tracy Farr Jukka Jolkkonen Yajie Liang Michel M.Modo Paulo H.Rosado-de-Castro Karsten Ruscher Yan-Jiang Wang Haitao Wu Marietta Zille Shen Li Johannes Boltze 

机构地区：[1]Beijing Institute of Brain Disorders,Capital Medical University,Beijing,China [2]Department of Diagnostic Radiology and Nuclear Medicine,Center for Advanced Imaging Research,University of Maryland,Baltimore,Maryland,USA [3]Department of Cardiology,Erasmus MC Rotterdam,University Medical Center Rotterdam,Rotterdam,The Netherlands [4]Department of Neurology,Center for Translational Neuro‐and Behavioral Sciences(C‐TNBS),University Clinics Essen,Essen,Germany [5]Department of Anatomy,Brain Health Research Center and Brain Research New Zealand,Dunedin,New Zealand [6]Medical School,Queen's Medical Centre,University of Nottingham,Nottingham,UK [7]A.I.Virtanen Institute for Molecular Sciences,University of Eastern Finland,Kuopio,Finland [8]McGowan Institute for Regenerative Medicine,University of Pittsburgh,Pittsburgh,Pennsylvania,USA [9]Department of Radiology,University of Pittsburgh,Pittsburgh,Pennsylvania,USA [10]Department of Bioengineering,University of Pittsburgh,Pittsburgh,Pennsylvania,USA [11]Department of Anatomy and Department of Radiology,School of Medicine,Institute of Biomedical Sciences,Federal University of Rio de Janeiro,Rio de Janeiro,Brazil [12]Laboratory for Experimental Brain Research,University of Lund,Lund,Sweden [13]Department of Neurology,Daping Hospital,Center for Clinical Neuroscience,Chongqing,China [14]Department of Neurobiology,Beijing Institute of Basic Medical Sciences,Beijing,China [15]Department of Pharmaceutical Sciences,Division of Pharmacology and Toxicology,University of Vienna,Vienna,Austria [16]Department of Neurology and Psychiatry,Beijing Shijitan Hospital,Capital Medical University,Beijing,China [17]School of Life Sciences,University of Warwick,Coventry,UK

出　　处：《Neuroprotection》2023年第1期5-8,共4页神经保护（英文）

基　　金：Support of the State of Rio de Janeiro,Grant/Award Numbers:202.751/2018,210.825/2021,201.460/2022;National Institute of Health,Grant/Award Number:NIH/NINDS R03NS123733;Deutsche Forschungsgemeinschaft,Grant/Award Number:CA 2642/1-1。

摘　　要：Translational medicine in neurodegenerative and neurovascular diseases is approaching a breakthrough point.Recent years have led to dramatic progress in both experimental and clinical research.Based on a much better and continuously increasing understanding of disease mechanisms,progression and pathophysiology,new therapies with an improved translational potential to protect tissue either against acute or chronic degeneration and even approaches potentially capable of repairing damaged brain tissue are emerging.

关 键 词：CYTOPROTECTION nervous system repair NEURODEGENERATION NEUROPROTECTION neurovasculardiseases translational research 

分 类 号：R741[医药卫生—神经病学与精神病学]